Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCTD12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FADS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SHISA8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CHD5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DDX28 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | PCNA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | STK33 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FAM69B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TAF6L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |